Industrial Strength Bio Past Seminars
2011
February 2, 2011
Andrew Lees, PhD
Scientific Director and Founder, Fina Biosolutions
Biotech Start-ups
February 2, 2011
Andrew Lees, PhD
Scientific Director and Founder, Fina Biosolutions
Mixed-Mode Chromatography
February 18, 2011
Bill Rich, PhD
Executive Director Alliance Management, Amgen Inc.
How to Build Strong Partnerships in Business
February 22, 2011
Sean Caffey, MD
Chairman, CEO and Cofounder, Replenish Inc.
The Formation and Development of Replenish Inc.
April 27, 2011
David L. Linemeyer, PhD
Vice President, Biology, Senomyx Inc.
A Biotechnological Approach to Flavor Discovery
2010
Jan. 26, 2010
Michael Palmer, M.S.M.E.
Mechanical Design Lead, Smart Technology
Freedom Innovations
Feb. 16, 2010
Matthew Jenusaitis, President & CEO of OCTANe
Mar. 23, 2010
Stan Rowe
Mar. 9, 2010
Larry Stambaugh
September 24, 2010
Jonathan Rosenblum
ActivX Biosciences: History of an emerging biotechnology powerhouse
October 8, 2010
Lyle Peschek
National Biotech Sales Manager, NovaBiomedical
Industry Trends: Interconnectivity in Achieving Optimal BioProcess Management
November 5, 2010
Dr. Tina Etcheverry
retired Director, CMC, Lucentis®
The Lucentis® product development story
November 10, 2010
Tony Page
principal, xIQ
Competitive Intelligence in the Life Sciences
December 7, 2010
Sean Sullivan
Vice President, Vical Inc.
Development of Plasmid DNA-based Vaccines for Treatment and Prevention of Infectious Disease
2009
September 22, 2009
Raymond Cohen, Symphony Medical
September 29, 2009
Perry Mullinix, Gilead Sciences
October 6, 2009
Vytas Pazmentas, Aubrey Group
October 13, 2009
Steven McCormack, Intelligent Medical Implants GMbH
October 20, 2009
Larry Stambaugh, Ridge Diagnostics
October 27, 2009
Steve Zweig, CliniSense Corporation
November 10, 2009
Jason Pyle, Sapphire
November 17, 2009
Bob Baltera, Amira Pharmaceuticals
2008
October 7, 2008
Avi Spier, Genomics Institute of the Novartis Research Foundation
October 14, 2008
Gregg Lapointe, Sigma-Tau Pharmaceuticals
October 21, 2008
Larry Wheeler, Allergan
November 18, 2008
Paul Glyer, Beckman-Coulter
December 2, 2008
Hari Patel, Genentech
March 24, 2008
David Rozzell, PhD, Solidus Biosciences
March 11, 2008
Pradip Mukerji, PhD
Vice President Strategic Expansion
Abbott Nutritionals
March 4, 2008
"Effective Biotech Marketing"
Ann Miller MD
Consultant
February 26, 2008
"Formulation Development of Protein Drugs"
Steve Shire, Ph.D.
Staff Scientist and Group Leader
Genentech Inc.
February 12, 2008
David Margolese, Ph.D.
V.P., Technology Development
ORFID Corp.
Title to be announced
2007
December 4, 2007
Note: Introduction, approximately 6 minutes
Dr. Jerald Feitelson, Ph.D, Business Development, IP & Alliance Management, Beckman Coulter
Introduced by Animesh Ray
November 27, 2007
Tom Berryman, President & CEO, Wavetec Vision Systems Inc.
Introduced by Gail Baura
November 6, 2007
Mark Reynolds, Gen-Probe Inc.
Introduced by Jim Sterling
October 30, 2007
Jay Hagen, President, Amgen Ventures
Introduced by Steve Casper
October 23, 2007
Joseph H. Schulman, PhD, President & Chief Scientist, Alfred E. Mann Foundation for Biomedical Research
Introduced by Molly Schmid
2006
October 24, 2006
Dr. Joey M. Studts
Principal Scientist, Boehringer Ingelheim
Eukaryotic Cells Ride the Wave: Expanding the Drug Discovery Pipeline by Improving Protein Production Technology 
(2.5 MB)